カテゴリー： QYResearch, 世界, 医療/バイオ

カプトプリル錠のグローバル市場2023年：25mg、12.5mg

◆英語タイトル：Global Captopril Tablets Market Research Report 2023

QYResearchが発行した調査報告書（QYR23MA8709）◆商品コード：QYR23MA8709
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2023年3月（※2025年版があります。お問い合わせください。）
◆ページ数：95
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥429,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥643,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥858,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

本調査レポートは世界のカプトプリル錠市場について調査・分析し、世界のカプトプリル錠市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（25mg、12.5mg）、用途別セグメント分析（高血圧、急性うっ血性心不全、慢性うっ血性心不全）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Wockhardt、Tecoland、Farmhispania、Azelis Deutschland Pharma、Kerui Pharmaceutical、Humanwell Pharmaceutical、Hengcheng Pharmaceutical、Hengwei Pharmaceutical、Zhongfu Pharmaceutical、Likang Pharmaceutical、Changjiang Pharmaceutical、Baiyunshan Pharmaceutical、Huaxin Pharmaceuticalなどが含まれています。世界のカプトプリル錠市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、カプトプリル錠市場規模を推定する際に考慮しました。

・カプトプリル錠市場の概要
- 製品の定義
- カプトプリル錠のタイプ別セグメント
- 世界のカプトプリル錠市場規模：タイプ別分析（25mg、12.5mg）
- カプトプリル錠の用途別セグメント
- 世界のカプトプリル錠市場規模：用途別分析（高血圧、急性うっ血性心不全、慢性うっ血性心不全）
- 世界のカプトプリル錠市場規模予測（2018年-2029年）
- カプトプリル錠の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- カプトプリル錠市場の競争状況およびトレンド

・カプトプリル錠の地域別市場規模
- 北米のカプトプリル錠市場規模（2018年-2029年）
- アメリカのカプトプリル錠市場規模（2018年-2029年）
- ヨーロッパのカプトプリル錠市場規模（2018年-2029年）
- アジア太平洋のカプトプリル錠市場規模（2018年-2029年）
- 中国のカプトプリル錠市場規模（2018年-2029年）
- 日本のカプトプリル錠市場規模（2018年-2029年）
- 韓国のカプトプリル錠市場規模（2018年-2029年）
- インドのカプトプリル錠市場規模（2018年-2029年）
- オーストラリアのカプトプリル錠市場規模（2018年-2029年）
- 中南米のカプトプリル錠市場規模（2018年-2029年）
- 中東・アフリカのカプトプリル錠市場規模（2018年-2029年）

・タイプ別セグメント：25mg、12.5mg
- 世界のカプトプリル錠のタイプ別販売量（2018年-2023年）
- 世界のカプトプリル錠のタイプ別売上（2018年-2023年）
- 世界のカプトプリル錠のタイプ別価格

・用途別セグメント：高血圧、急性うっ血性心不全、慢性うっ血性心不全
- 世界のカプトプリル錠の用途別販売量（2018年-2023年）
- 世界のカプトプリル錠の用途別売上（2018年-2023年）
- 世界のカプトプリル錠の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Wockhardt、Tecoland、Farmhispania、Azelis Deutschland Pharma、Kerui Pharmaceutical、Humanwell Pharmaceutical、Hengcheng Pharmaceutical、Hengwei Pharmaceutical、Zhongfu Pharmaceutical、Likang Pharmaceutical、Changjiang Pharmaceutical、Baiyunshan Pharmaceutical、Huaxin Pharmaceutical

・産業チェーンと販売チャネルの分析
- カプトプリル錠産業チェーン分析
- カプトプリル錠の主要原材料
- カプトプリル錠の販売チャネル
- カプトプリル錠のディストリビューター
- カプトプリル錠の主要顧客

・カプトプリル錠市場ダイナミクス
- カプトプリル錠の業界動向
- カプトプリル錠市場の成長ドライバ、課題、阻害要因

・調査成果および結論

・調査方法とデータソース

Highlights
The global Captopril Tablets market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Captopril Tablets is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Captopril Tablets is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Captopril Tablets include Wockhardt, Tecoland, Farmhispania, Azelis Deutschland Pharma, Kerui Pharmaceutical, Humanwell Pharmaceutical, Hengcheng Pharmaceutical, Hengwei Pharmaceutical and Zhongfu Pharmaceutical, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Captopril Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Captopril Tablets.
The Captopril Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Captopril Tablets market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Captopril Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Wockhardt
Tecoland
Farmhispania
Azelis Deutschland Pharma
Kerui Pharmaceutical
Humanwell Pharmaceutical
Hengcheng Pharmaceutical
Hengwei Pharmaceutical
Zhongfu Pharmaceutical
Likang Pharmaceutical
Changjiang Pharmaceutical
Baiyunshan Pharmaceutical
Huaxin Pharmaceutical
Segment by Type
Specification 25mg
Specification 12.5mg
Segment by Application
Hypertension
Acute Congestive Heart Failure
Chronic Congestive Heart Failure
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Captopril Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Captopril Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Captopril Tablets Market Overview
1.1 Product Overview and Scope of Captopril Tablets
1.2 Captopril Tablets Segment by Type
1.2.1 Global Captopril Tablets Market Value Comparison by Type (2023-2029)
1.2.2 Specification 25mg
1.2.3 Specification 12.5mg
1.3 Captopril Tablets Segment by Application
1.3.1 Global Captopril Tablets Market Value by Application: (2023-2029)
1.3.2 Hypertension
1.3.3 Acute Congestive Heart Failure
1.3.4 Chronic Congestive Heart Failure
1.4 Global Captopril Tablets Market Size Estimates and Forecasts
1.4.1 Global Captopril Tablets Revenue 2018-2029
1.4.2 Global Captopril Tablets Sales 2018-2029
1.4.3 Global Captopril Tablets Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Captopril Tablets Market Competition by Manufacturers
2.1 Global Captopril Tablets Sales Market Share by Manufacturers (2018-2023)
2.2 Global Captopril Tablets Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Captopril Tablets Average Price by Manufacturers (2018-2023)
2.4 Global Captopril Tablets Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Captopril Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Captopril Tablets, Product Type & Application
2.7 Captopril Tablets Market Competitive Situation and Trends
2.7.1 Captopril Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Captopril Tablets Players Market Share by Revenue
2.7.3 Global Captopril Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Captopril Tablets Retrospective Market Scenario by Region
3.1 Global Captopril Tablets Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Captopril Tablets Global Captopril Tablets Sales by Region: 2018-2029
3.2.1 Global Captopril Tablets Sales by Region: 2018-2023
3.2.2 Global Captopril Tablets Sales by Region: 2024-2029
3.3 Global Captopril Tablets Global Captopril Tablets Revenue by Region: 2018-2029
3.3.1 Global Captopril Tablets Revenue by Region: 2018-2023
3.3.2 Global Captopril Tablets Revenue by Region: 2024-2029
3.4 North America Captopril Tablets Market Facts & Figures by Country
3.4.1 North America Captopril Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Captopril Tablets Sales by Country (2018-2029)
3.4.3 North America Captopril Tablets Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Captopril Tablets Market Facts & Figures by Country
3.5.1 Europe Captopril Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Captopril Tablets Sales by Country (2018-2029)
3.5.3 Europe Captopril Tablets Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Captopril Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Captopril Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Captopril Tablets Sales by Country (2018-2029)
3.6.3 Asia Pacific Captopril Tablets Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Captopril Tablets Market Facts & Figures by Country
3.7.1 Latin America Captopril Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Captopril Tablets Sales by Country (2018-2029)
3.7.3 Latin America Captopril Tablets Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Captopril Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Captopril Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Captopril Tablets Sales by Country (2018-2029)
3.8.3 Middle East and Africa Captopril Tablets Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Captopril Tablets Sales by Type (2018-2029)
4.1.1 Global Captopril Tablets Sales by Type (2018-2023)
4.1.2 Global Captopril Tablets Sales by Type (2024-2029)
4.1.3 Global Captopril Tablets Sales Market Share by Type (2018-2029)
4.2 Global Captopril Tablets Revenue by Type (2018-2029)
4.2.1 Global Captopril Tablets Revenue by Type (2018-2023)
4.2.2 Global Captopril Tablets Revenue by Type (2024-2029)
4.2.3 Global Captopril Tablets Revenue Market Share by Type (2018-2029)
4.3 Global Captopril Tablets Price by Type (2018-2029)
5 Segment by Application
5.1 Global Captopril Tablets Sales by Application (2018-2029)
5.1.1 Global Captopril Tablets Sales by Application (2018-2023)
5.1.2 Global Captopril Tablets Sales by Application (2024-2029)
5.1.3 Global Captopril Tablets Sales Market Share by Application (2018-2029)
5.2 Global Captopril Tablets Revenue by Application (2018-2029)
5.2.1 Global Captopril Tablets Revenue by Application (2018-2023)
5.2.2 Global Captopril Tablets Revenue by Application (2024-2029)
5.2.3 Global Captopril Tablets Revenue Market Share by Application (2018-2029)
5.3 Global Captopril Tablets Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Wockhardt
6.1.1 Wockhardt Corporation Information
6.1.2 Wockhardt Description and Business Overview
6.1.3 Wockhardt Captopril Tablets Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Wockhardt Captopril Tablets Product Portfolio
6.1.5 Wockhardt Recent Developments/Updates
6.2 Tecoland
6.2.1 Tecoland Corporation Information
6.2.2 Tecoland Description and Business Overview
6.2.3 Tecoland Captopril Tablets Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Tecoland Captopril Tablets Product Portfolio
6.2.5 Tecoland Recent Developments/Updates
6.3 Farmhispania
6.3.1 Farmhispania Corporation Information
6.3.2 Farmhispania Description and Business Overview
6.3.3 Farmhispania Captopril Tablets Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Farmhispania Captopril Tablets Product Portfolio
6.3.5 Farmhispania Recent Developments/Updates
6.4 Azelis Deutschland Pharma
6.4.1 Azelis Deutschland Pharma Corporation Information
6.4.2 Azelis Deutschland Pharma Description and Business Overview
6.4.3 Azelis Deutschland Pharma Captopril Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Azelis Deutschland Pharma Captopril Tablets Product Portfolio
6.4.5 Azelis Deutschland Pharma Recent Developments/Updates
6.5 Kerui Pharmaceutical
6.5.1 Kerui Pharmaceutical Corporation Information
6.5.2 Kerui Pharmaceutical Description and Business Overview
6.5.3 Kerui Pharmaceutical Captopril Tablets Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Kerui Pharmaceutical Captopril Tablets Product Portfolio
6.5.5 Kerui Pharmaceutical Recent Developments/Updates
6.6 Humanwell Pharmaceutical
6.6.1 Humanwell Pharmaceutical Corporation Information
6.6.2 Humanwell Pharmaceutical Description and Business Overview
6.6.3 Humanwell Pharmaceutical Captopril Tablets Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Humanwell Pharmaceutical Captopril Tablets Product Portfolio
6.6.5 Humanwell Pharmaceutical Recent Developments/Updates
6.7 Hengcheng Pharmaceutical
6.6.1 Hengcheng Pharmaceutical Corporation Information
6.6.2 Hengcheng Pharmaceutical Description and Business Overview
6.6.3 Hengcheng Pharmaceutical Captopril Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Hengcheng Pharmaceutical Captopril Tablets Product Portfolio
6.7.5 Hengcheng Pharmaceutical Recent Developments/Updates
6.8 Hengwei Pharmaceutical
6.8.1 Hengwei Pharmaceutical Corporation Information
6.8.2 Hengwei Pharmaceutical Description and Business Overview
6.8.3 Hengwei Pharmaceutical Captopril Tablets Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Hengwei Pharmaceutical Captopril Tablets Product Portfolio
6.8.5 Hengwei Pharmaceutical Recent Developments/Updates
6.9 Zhongfu Pharmaceutical
6.9.1 Zhongfu Pharmaceutical Corporation Information
6.9.2 Zhongfu Pharmaceutical Description and Business Overview
6.9.3 Zhongfu Pharmaceutical Captopril Tablets Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Zhongfu Pharmaceutical Captopril Tablets Product Portfolio
6.9.5 Zhongfu Pharmaceutical Recent Developments/Updates
6.10 Likang Pharmaceutical
6.10.1 Likang Pharmaceutical Corporation Information
6.10.2 Likang Pharmaceutical Description and Business Overview
6.10.3 Likang Pharmaceutical Captopril Tablets Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Likang Pharmaceutical Captopril Tablets Product Portfolio
6.10.5 Likang Pharmaceutical Recent Developments/Updates
6.11 Changjiang Pharmaceutical
6.11.1 Changjiang Pharmaceutical Corporation Information
6.11.2 Changjiang Pharmaceutical Captopril Tablets Description and Business Overview
6.11.3 Changjiang Pharmaceutical Captopril Tablets Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Changjiang Pharmaceutical Captopril Tablets Product Portfolio
6.11.5 Changjiang Pharmaceutical Recent Developments/Updates
6.12 Baiyunshan Pharmaceutical
6.12.1 Baiyunshan Pharmaceutical Corporation Information
6.12.2 Baiyunshan Pharmaceutical Captopril Tablets Description and Business Overview
6.12.3 Baiyunshan Pharmaceutical Captopril Tablets Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Baiyunshan Pharmaceutical Captopril Tablets Product Portfolio
6.12.5 Baiyunshan Pharmaceutical Recent Developments/Updates
6.13 Huaxin Pharmaceutical
6.13.1 Huaxin Pharmaceutical Corporation Information
6.13.2 Huaxin Pharmaceutical Captopril Tablets Description and Business Overview
6.13.3 Huaxin Pharmaceutical Captopril Tablets Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Huaxin Pharmaceutical Captopril Tablets Product Portfolio
6.13.5 Huaxin Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Captopril Tablets Industry Chain Analysis
7.2 Captopril Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Captopril Tablets Production Mode & Process
7.4 Captopril Tablets Sales and Marketing
7.4.1 Captopril Tablets Sales Channels
7.4.2 Captopril Tablets Distributors
7.5 Captopril Tablets Customers
8 Captopril Tablets Market Dynamics
8.1 Captopril Tablets Industry Trends
8.2 Captopril Tablets Market Drivers
8.3 Captopril Tablets Market Challenges
8.4 Captopril Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ カプトプリル錠のグローバル市場2023年：25mg、12.5mg(Global Captopril Tablets Market Research Report 2023)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • メトトレキサート錠のグローバル市場2023年：2mg、2.5mg、10mg、その他
  • ボルチオキセチン臭化水素酸塩錠のグローバル市場2023年：5mg、10mg、20mg
  • グリコピロレート錠のグローバル市場2023年：0.5mg、1mg、2mg
  • 炭酸リチウム医療用錠剤のグローバル市場2023年：徐放錠、普通錠
  • ファビピラビル錠のグローバル市場2023年：ブランド薬、ジェネリック薬

    • ◆H&Iグローバルリサーチのお客様（例）◆